Cargando…
First person – Danny Legge
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Danny Legge is first author on ‘BCL-3 promotes a cancer stem cell phenotype by enhanc...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451424/ http://dx.doi.org/10.1242/dmm.039412 |
_version_ | 1783409189809291264 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Danny Legge is first author on ‘BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells’, published in DMM. Danny conducted the research described in this article while a PhD student in Professor Ann Williams's lab at Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, University of Bristol, UK. He is now a postdoc in the lab of Dr Keith Brown at Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, UK, investigating the role of cancer stem cells in colorectal cancer. |
format | Online Article Text |
id | pubmed-6451424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-64514242019-04-08 First person – Danny Legge Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Danny Legge is first author on ‘BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells’, published in DMM. Danny conducted the research described in this article while a PhD student in Professor Ann Williams's lab at Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, University of Bristol, UK. He is now a postdoc in the lab of Dr Keith Brown at Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, UK, investigating the role of cancer stem cells in colorectal cancer. The Company of Biologists Ltd 2019-03-01 2019-03-07 /pmc/articles/PMC6451424/ http://dx.doi.org/10.1242/dmm.039412 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Danny Legge |
title | First person – Danny Legge |
title_full | First person – Danny Legge |
title_fullStr | First person – Danny Legge |
title_full_unstemmed | First person – Danny Legge |
title_short | First person – Danny Legge |
title_sort | first person – danny legge |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451424/ http://dx.doi.org/10.1242/dmm.039412 |